Ose Immunotherapeutics annual debt-to-assets ratio
2020
2021
2022
2023
2024
2025
Ose Immunotherapeutics Debt-to-Assets Ratio Growth & History (OSE)
Ose Immunotherapeutics's debt-to-assets ratio was 0.45 for fiscal 2025.
View full Ose Immunotherapeutics company overviewOse Immunotherapeutics annual debt-to-assets ratio history
| Fiscal year | Period ended | Debt-to-assets ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 0.45 | 0.08 | +20.54% |
| 2024 | 2024-12-31 | 0.37 | −0.19 | −33.33% |
| 2023 | 2023-12-31 | 0.56 | 0.07 | +14.37% |
| 2022 | 2022-12-31 | 0.49 | 0.12 | +33.90% |
| 2021 | 2021-12-31 | 0.36 | 0.16 | +81.13% |
| 2020 | 2020-12-31 | 0.20 | — | — |
Ose Immunotherapeutics quarterly debt-to-assets ratio
Q4.24
Q4.25
| Fiscal quarter | Period ended | Debt-to-assets ratio | Change | YoY change |
|---|---|---|---|---|
| Q4 2025 | 2025-12-31 | 0.45 | 0.08 | +20.55% |
| Q4 2024 | 2024-12-31 | 0.37 | — | — |
Ose Immunotherapeutics debt-to-assets ratio trends
Over the last five fiscal years, Ose Immunotherapeutics's debt-to-assets ratio increased from 0.20 to 0.45, a change of 0.25. The latest reported quarter, Q4 2025, shows 0.45.
About the metric
What the debt-to-assets ratio means
The debt-to-assets ratio shows the portion of a company’s reported assets financed with interest-bearing debt. It is a leverage measure and should not be confused with total liabilities divided by assets.
Calculation and source
How debt-to-assets is calculated
TickerStat calculates debt-to-assets as total interest-bearing debt divided by total assets at the same reporting-period end. Periods with missing debt or non-positive assets are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Ose Immunotherapeutics source filings ↗